Skip to main content
Erschienen in: BMC Neurology 1/2016

Open Access 01.12.2016 | Research article

Activities of daily living questionnaire from patients’ perspectives in Parkinson’s disease: a cross-sectional study

verfasst von: Su-Yun Lee, Sung Kwan Kim, Sang-Myung Cheon, Jung-Wook Seo, Min Ah Kim, Jae Woo Kim

Erschienen in: BMC Neurology | Ausgabe 1/2016

Abstract

Background

The aim of this study was to develop an assessment tool for activities of daily living (ADL) from the perspective of patients with Parkinson’s disease (PD) and examine the validity and reliability of the assessment.

Methods

A preliminary 45-item questionnaire was developed through intensive interviews with 54 patients with PD and administered to another group of 248 patients with PD. Based on clinical and statistical analyses, 20 ADL-items were selected. The final 20-item questionnaire was examined in the other group of 59 patients with PD.

Results

The new ADL questionnaire showed high internal consistency (Cronbach’s α, 0.962–0.966) and acceptable test-retest reliability (0.632–0.984). Concurrent validity was shown as a significant positive correlation between the new ADL questionnaire and other ADL or clinical instruments. The Hoehn and Yahr stage showed the highest degree of correlation with the new ADL questionnaire, followed by the other ADL scales (Schwab and England ADL and the ADL subscore of the Unified Parkinson’s Disease Rating Scale). Additionally, a regression analysis was conducted with the disease-specific quality of life questionnaire, and the new ADL questionnaire was the most powerful predictor of quality of life among the clinical instruments.

Conclusions

The new ADL questionnaire is a valid tool for assessing ADL from the perspectives of patients with PD.
Hinweise

Competing interests

The authors declare that they have no competing interests.

Authors’ contributions

S-Y Lee and S-M Cheon participated in the design of the study, interpretation and analysis of data, and drafting the manuscript. SK Kim participated in the design of the study, developing the questionnaire, and drafting the manuscript. J-W Seo performed the statistical analysis. MA Kim helped developing the questionnaire. JW Kim participated in the design of the study and revising the manuscript. All authors have read and approve of the final version of the manuscript.
Abkürzungen
PDQL
Parkinson’s disease quality of life
ADL
Activities of daily living
HY
Hoehn and Yahr
K-MMSE
Korean version of mini-mental status examination
PD
Parkinson’s disease
SEADL
Schwab and England ADL scale
UPDRS
Unified Parkinson’s disease rating scale

Background

Parkinson’s disease (PD) is a chronic disorder due to the progressive degeneration of dopamine-producing cells in brain structures, including the substantia nigra [1]. PD is characterized by motor disturbances, such as tremor, bradykinesia, rigidity, and postural instability. Clinical presentations of PD also include a variety of non-motor symptoms. Thus, patients with PD are vulnerable to decreased activities of daily living (ADL), such as walking, talking, swallowing, or simple tasks like bathing or dressing [2].
Despite the recent development of medical, surgical, and rehabilitative treatments, PD remains a progressive condition; there are no proven management strategies to reverse or halt its pathological processes. Patients with PD are at increased risk for decreased activities of daily living (ADL) with progression of the disease, particularly those requiring coordination and balance [35]. The treatment goal for patients with PD is to focus on symptoms and improve ADL. Therefore, it is mandatory to assess the ADL of patients with PD, which is essential for evaluating the effectiveness of symptomatic and potentially disease-modifying treatments.
Some studies have focused on the ADL of patients with PD. However, these studies have revealed limitations due to a lack of reliable and valid tools for assessing ADL from the patient’s perspective [610]. The Unified Parkinson’s Disease Rating Scale (UPDRS) is widely used to assess mentation, ADL, motor symptoms, and treatment complications in patients with PD [11]. The advantages of the ADL subsection of the UPDRS have been well described [12, 13]. However, it has been criticized due to its ambiguity and redundancy of items, such as items overlapping in the ADL and motor sections, and a lack of the patient’s perspective has also been reported [11, 14]. It also requires an interview by an examiner. The new version of the UPDRS includes motor experiences associated with ADL that are self-evaluated by patients or their caregivers [14]. However, the new version does not differ greatly from the old version and fails to evaluate ADL comprehensively.
Improvements in motor symptoms, which are unresponsive to medical and surgical treatments, have been observed in patients with PD with recent advancements in rehabilitation therapy [15]. These symptoms are related to balance, walking, and mobility, all of which constitute the ADL of patients with PD. However, the UPDRS shows limited validity for assessing the effects of physiotherapy on balance and mobility, both of which are essential when measuring the ADL of patients with PD [16].
We developed a new ADL questionnaire from the patient’s perspective and assessed its validity and reliability in this cross-sectional study.

Methods

Study patients

Patients with PD were recruited consecutively from an outpatient clinic in a specialized center of a referral hospital. Patients were diagnosed with clinically probable PD according to the United Kingdom Parkinson’s Disease Society Brain Bank clinical diagnostic criteria [17]. Patients with cognitive impairment based on a Korean Mini-Mental Status Examination (K-MMSE) score < 24 and patients without sufficient cognitive or physical ability to cooperate were excluded [18]. Patients who had other medical problems that seriously affected ADL, such as stroke, osteoarthritis, and angina, were also excluded.

Development of the preliminary 45-item questionnaire

Movement disorder and neurorehabilitation specialists reviewed motor aspects of disabilities of daily living in patients with PD with reference to various ADL scales and collected ADL items [1925]. An open and intensive interview was performed with 54 patients with PD; they were asked whether they had disability in a collection of ADL items and were asked to add any other ADL items experienced during their daily lives. The preliminary 45-item ADL questionnaire was prepared and included household, outdoor, and social activities (Appendix 1).

Selection of the final 20-item questionnaire

Another group of 248 patients with PD (90 men and 158 women; mean age, 67.9 ± 9.2 years; mean K-MMSE score, 26.2 ± 3.8 points; mean Hoehn and Yahr [HY] stage, 2.4 ± 0.6) were asked to select the items that they found difficult in their daily living and were asked to select the three items that were most important to them using the preliminary 45-item questionnaire.
Clinical and statistical analyses were performed to select the ADL items. The frequency of items reflecting patient’s experience and importance and clinical significance for infrequent items, such as swallowing, were included in the clinical analyses. Statistical analyses were conducted using maximum likelihood to estimate the factor structure matrix. The number of items was determined using parallel analysis and the scree test. We used the Promax (Kappa = 2) oblique rotation method to simplify the structure, and each item was selected and classified based on a factor loading > 0.4.
All items were given a score on a 5-point scale (0: no impairment of ADL and 5: inability to perform ADL) (Appendix 2).

Validation of the final 20-item questionnaire

Fifty-nine patients with mild-to-moderate PD were additionally recruited to validate the final 20-item questionnaire (Table 1). We assessed internal consistency of the new ADL questionnaire using Cronbach’s α. In addition, we performed repeated interviews at a 4-week interval to assess test-retest reliability. Concurrent validity was analyzed by the correlation between the new ADL questionnaire and other clinical instruments including the UPDRS, the Schwab and England ADL (SEADL) scale, Beck’s Depression Inventory [26], the Autonomic Dysfunction Questionnaire [27], the Fatigue Severity Scale [28], and the Parkinson’s disease quality of life (PDQL) questionnaire [29]. A simple regression analysis was conducted for the PDQL questionnaire to evaluate the influence of various clinical instruments on quality of life.
Table 1
Baseline and clinical characteristics of the 59 patients who were evaluated to validate the 20-item questionnaire
 
Mean ± SD
Number (male-to-female ratio)
59 (22:37)
Age (years)
66.85 ± 8.25
Disease duration (years)
6.14 ± 4.80
Treatment duration (years)
4.43 ± 4.00
The daily dose of levodopa (mg/day)
540.00 ± 296.21
K-MMSE
26.49 ± 2.85
New questionnaire
23.24 ± 22.29
HY stage
2.42 ± 0.58
UPDRS
45.78 ± 18.49
 Mentation
3.26 ± 2.05
 ADL
11.88 ± 6.22
 Motor
27.91 ± 11.05
 Complications
2.73 ± 2.97
SEADL
77.59 ± 15.89
BDI
22.38 ± 11.53
PDQL
115.53 ± 39.93
 Parkinson’s symptoms
42.51 ± 14.14
 Systemic symptoms
25.27 ± 9.64
 Social function
19.21 ± 7.18
 Emotional function subscore
28.54 ± 10.80
ADQ
19.21 ± 12.42
FSS
36.20 ± 15.69
K-MMSE Korean Mini-Mental Status Examination, HY Hoehn and Yahr, UPDRS Unified Parkinson’s Disease Rating Scale, ADL Activities of Daily Living, SEADL Schwab and England ADL, BDI Beck’s Depression Inventory, PDQL Parkinson’s Disease Quality of Life, ADQ Autonomic Dysfunction Questionnaire, FSS Fatigue Severity Scale

Statistical analysis

All data are expressed as mean ± standard deviation for continuous variables and as proportions of patients (%) for categorical variable. The univariate analysis included Student’s t-test and Pearson’s chi-square test, as appropriate, to analyze differences between the two groups. A correlation analysis was conducted using Spearman’s method. The statistical analysis was performed using SPSS ver. 19.0 for Windows software (SPSS Inc., Chicago, IL, USA). A P-value ≤ 0.05 was considered significant.

Results

Evaluation of ADL with the preliminary 45-item questionnaire in 248 patients with PD

The most common ADL items experienced by patients were getting up (61.7 %), dressing (57.7 %), and moving objects (56.9 %) (Table 2). The most important ADL items selected by patients were “walking outside”, “using a spoon and chopsticks”, and “getting up”. Some differences in the frequencies for selected items were detected according to sex, such as “driving” for men, “preparing a meal”, “washing dishes”, “cleaning”, and “washing clothes” for women (chi-square test, P ≤ 0.05).
Table 2
The most common disabilities during daily activities in patients with Parkinson’s disease using the preliminary 45-item questionnaire
Items of ADL
Number
Percent
Getting up from the floor
153
61.7
Dressing
143
57.7
Moving objects
141
56.9
Wearing shoes
136
54.8
Writing
134
54.0
Walking inside
133
53.6
Walking outside
131
52.8
Standing
130
52.4
Turning around in bed
126
50.8
Sitting on the floor
126
50.8
ADL Activities of Daily Living
A positive correlation was observed between the number of items patients found difficult and severity of the disease, as shown by the HY stage (Table 3).
Table 3
The most common and important items in patients with Parkinson's disease according to Hoehn and Yahr stage using the preliminary 45 item questionnaire
HY stage
Number of items
Most common items
Most important items
1
1.29 ± 1.60
Getting up from the floor
Exercise
  
Sitting on the floor
Walking outside
  
Walking outside
Grasping and releasing objects
2
11.31 ± 11.06
Dressing
Walking outside
  
Getting up from the floor
Getting up from the floor
  
Writing
Using a spoon and chopsticks
2.5
20.30 ± 12.04
Getting up from the floor
Walking outside
  
Transferring objects
Sitting on the floor
  
Wearing shoes
Getting up from the floor
3
24.18 ± 12.81
Getting up from the floor
Walking outside
  
Moving objects
Taking the first step
  
Taking the first step
Getting in/out of bed
4–5
34.50 ± 7.52
Dressing
Waking outside
  
Getting in/out of a car
Using the toilet
  
Taking a bath/shower
Getting in/out of bed
HY Hoehn and Yahr

Validation of the new ADL questionnaire in 59 patients with PD

The internal consistency of the new questionnaire was acceptable with an item-total correlation (range, 0.523–0.898) and high consistency, as shown by Cronbach’s α of 0.962–0.966. Test-retest reliability was acceptable, reached at 0.632–0.984. Concurrent validity was detected as significant correlations between scores on the new ADL questionnaire and other ADL scales (SEADL and the ADL subscore of the UPDRS). The other clinical instruments were also correlated with the new ADL questionnaire, except the MMSE (Table 4).
Table 4
Correlations between the new questionnaire and other clinical instruments
 
Coefficient
P-value
K-MMSE
−0.066
0.621
HY stage
0.682
<0.001
SEADL
−0.617
<0.001
UPDRS
0.521
<0.001
 Mentation’
0.313
0.021
 ADL’
0.608
<0.001
 Motor’
0.322
0.018
 Complications’
0.562
<0.001
BDI
0.586
<0.001
PDQL
−0.605
<0.001
 Parkinson’s symptoms’
−0.596
<0.001
 Systemic symptoms’
−0.527
<0.001
 Social function’
−0.589
<0.001
 Emotional function’
−0.594
<0.001
ADQ
0.480
0.000
FSS
0.449
0.001
K-MMSE Korean Mini-Mental Status Examination, HY Hoehn and Yahr, SEADL Schwab and England ADL, UPDRS Unified Parkinson’s Disease Rating Scale, ADL Activities of Daily Living, BDI Beck’s Depression Inventory, PDQL Parkinson’s Disease Quality of Life, ADQ Autonomic Dysfunction Questionnaire, FSS Fatigue Severity Scale
The regression analysis for quality of life showed that the new ADL questionnaire was the most powerful predictor for quality of life in patients with PD followed by the ADL subscore of the UPDRS (Table 5). The new questionnaire and the ADL subscore of the UPDRS were the strongest predictors of the PDQL after adjusting for age, disease duration, treatment, and daily levodopa dosage (adjusted R 2 values, 0.456 and 0.464, respectively).
Table 5
Results of a simple regression analysis for the Parkinson’s Disease Quality of Life Score
 
P-value
R 2
New questionnaire
<0.001
0.366
K-MMSE
0.746
0.002
HY stage
0.003
0.162
SEADL
<0.001
0.280
UPDRS
<0.001
0.232
 Mentation’
0.005
0.150
 ADL’
<0.001
0.335
 Motor’
0.035
0.088
 Complications’
<0.001
0.247
BDI
0.002
0.181
ADQ
0.011
0.128
FSS
0.238
0.030
K-MMSE Korean Mini-Mental Status Examination, HY Hoehn and Yahr, SEADL Schwab and England ADL, UPDRS Unified Parkinson’s Disease Rating Scale, ADL Activities of Daily Living, BDI Beck’s Depression Inventory, ADQ Autonomic Dysfunction Questionnaire, FSS Fatigue Severity Scale

Discussion

The number of ADL items that were difficult for patients with PD increased according to the HY stage using the 45-item questionnaire, indicating that progression of the disease increased ADL impairment. This finding suggests that items on the preliminary questionnaire covered ADL throughout the disease stages and comprehensively reflected the patient’s perspectives.
Some differences were found in the list of selected items according to HY stage. However, the most common and important items for the patients were similar at all HY stages. Getting up was the most common, and walking outside was the most important activity. These findings suggest that mobility deserves special attention compared to others activities during the daily lives of these patients.
Among the most frequently selected 10 items, only four (dressing, writing, walking, and turning around in bed) are present in the ADL section of the UPDRS. These findings suggest that the ADL section of the UPDRS may be insufficient to reflect the daily disabilities of patients with PD.
The validity of the new questionnaire was acceptable, as shown by the correlation with other clinical measures. Concurrent validity was reasonable based on the high correlation of the new questionnaire with other ADL and clinical instruments, except the K-MMSE. Given that cognitive function can greatly affect ADL, this result may be distorted due to the limited distribution of the K-MMSE scores based on the exclusion criteria of this study. The new questionnaire showed the highest degree of correlation with HY stage and also had a high degree of correlation with other clinical instruments, such as the SEADL and the ADL section of the UPDRS. Moreover, the motor subscore of the UPDRS was marginally correlated with the new ADL questionnaire, but it was less correlated than depression, autonomic dysfunction, and fatigue. This finding is consistent with a recent report that severity of motor symptoms, as expressed by the motor subscore of the UPDRS, has less impact on the health status of patients with PD than non-motor symptoms [30].
Quality of life may be the most important clinical measure representing the current status of patients with PD. Our results show that the new questionnaire was a strong predictor of quality of life in patients with PD among the clinical instruments evaluated in this study. A regression analysis showed that the new questionnaire and the ADL subscore of the UPDRS had strong predictive value for quality of life in patients with PD after adjusting of for age, disease duration, treatment, and daily levodopa dosage.
Several limitations of this study should be discussed. Different importance could be assigned to some items in different cultures, such as “getting up from or sitting on the floor”. Thus, it may be necessary to validate the new questionnaire in different cultural areas. Also, there could be some biases from the predominance women in recruited patients at the evaluation of preliminary 45-item questionnaire. And, the new questionnaire showed relatively weak correlation with motor part of UDPRS, compared to other scales. This finding could suggest that the new questionnaire might not be sensitive enough as an assessment tool for motor changes responsive to physical therapy. Finally, this study was conducted using a cross-sectional design. Therefore, we failed to assess the feasibility of the new questionnaire for detecting changes along the course of the disease. This deserves further longitudinal studies.
Despite these limitations, the new questionnaire has several advantages over other clinical instruments; it reflects actual patient disabilities during daily living based on a patient’s perspective. Changes in the ADL of patients could be easily and effectively evaluated, because the questionnaire is designed for self-administration. Thus, the new questionnaire is applicable to long-term follow-up in an actual clinical setting.

Conclusion

The new questionnaire developed based on the perspective of patients with PD was found to be a valid tool for assessing ADLs of patients with PD.
This study was approved by the Institutional Review Board of Dong-A University Hospital (No. 14–101) and patients submitted written informed consent.
Not applicable

Availability of data and materials

All the data supporting our findings is contained within the manuscript.

Funding

This study was supported by Dong-A University Research Fund (S-M Cheon).
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://​creativecommons.​org/​licenses/​by/​4.​0/​), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated.

Competing interests

The authors declare that they have no competing interests.

Authors’ contributions

S-Y Lee and S-M Cheon participated in the design of the study, interpretation and analysis of data, and drafting the manuscript. SK Kim participated in the design of the study, developing the questionnaire, and drafting the manuscript. J-W Seo performed the statistical analysis. MA Kim helped developing the questionnaire. JW Kim participated in the design of the study and revising the manuscript. All authors have read and approve of the final version of the manuscript.
Anhänge

Appendix

Appendix 1

Table 6
Preliminary 45-item questionnaire
Please check the daily activities that you find difficult to do during last week. Please list the three activities that are most important to you.
Household
Outdoor
 Getting in/out of bed
Taking the first step
 Turning around in bed
Walking outside
 Sitting on the floor
Turning
 Getting up from the floor
Stopping walking
 Dressing
Walking up/down stairs
 Sex life
Crossing the street
 
Running
 Sitting on and rising from a chair
Getting in/out of a car
 Sitting upright
Getting on/off of a bus or subway
 Standing
Driving a car
 Walking inside
 
 Grasping and releasing an object
If you (or the patient) cannot walk
 Moving an object
Moving from the bed or a chair to a wheelchair
 Writing
Using a wheelchair
 Wearing shoes
 
 
Social
 Brushing teeth
Talking
 Getting in/out of the bath
Using the phone
 Taking a bath/shower
Shopping
 Using the toilet
Going out
 
Walking around the neighborhood
 Preparing a meal
Working
 Using a spoon and chopsticks
Taking exercise
 Swallowing
Doing hobbies
 Washing the dishes
Traveling
 Cleaning the house
 
 Washing the clothes
Activities most important for you.
 
1.
If you find any other activities difficult that are not in this list, please list them below.
2.
 
3.

Appendix 2

Table 7
The new activities of daily living questionnaire
https://static-content.springer.com/image/art%3A10.1186%2Fs12883-016-0600-9/MediaObjects/12883_2016_600_Tab7_HTML.gif
Literatur
1.
Zurück zum Zitat Parkinson J. An essay on the shaking palsy. 1817. J Neuropsychiatry Clin Neurosci. 2002;14(2):223–36. discussion 222.CrossRefPubMed Parkinson J. An essay on the shaking palsy. 1817. J Neuropsychiatry Clin Neurosci. 2002;14(2):223–36. discussion 222.CrossRefPubMed
2.
Zurück zum Zitat Jankovic J. Parkinson's disease: clinical features and diagnosis. J Neurol Neurosurg Psychiatry. 2008;79(4):368–76.CrossRefPubMed Jankovic J. Parkinson's disease: clinical features and diagnosis. J Neurol Neurosurg Psychiatry. 2008;79(4):368–76.CrossRefPubMed
3.
Zurück zum Zitat Schrag A, Jahanshahi M, Quinn N. How does Parkinson's disease affect quality of life? A comparison with quality of life in the general population. Mov Disord. 2000;15(6):1112–8.CrossRefPubMed Schrag A, Jahanshahi M, Quinn N. How does Parkinson's disease affect quality of life? A comparison with quality of life in the general population. Mov Disord. 2000;15(6):1112–8.CrossRefPubMed
4.
Zurück zum Zitat Shulman LM, Gruber-Baldini AL, Anderson KE, Vaughan CG, Reich SG, Fishman PS, et al. The evolution of disability in Parkinson disease. Mov Disord. 2008;23(6):790–6.CrossRefPubMed Shulman LM, Gruber-Baldini AL, Anderson KE, Vaughan CG, Reich SG, Fishman PS, et al. The evolution of disability in Parkinson disease. Mov Disord. 2008;23(6):790–6.CrossRefPubMed
5.
Zurück zum Zitat Jankovic J, Kapadia AS. Functional decline in Parkinson disease. Arch Neurol. 2001;58(10):1611–5.CrossRefPubMed Jankovic J, Kapadia AS. Functional decline in Parkinson disease. Arch Neurol. 2001;58(10):1611–5.CrossRefPubMed
6.
Zurück zum Zitat Hobson JP, Edwards NI, Meara RJ. The Parkinson's Disease Activities of Daily Living Scale: a new simple and brief subjective measure of disability in Parkinson's disease. Clin Rehabil. 2001;15(3):241–6.CrossRefPubMed Hobson JP, Edwards NI, Meara RJ. The Parkinson's Disease Activities of Daily Living Scale: a new simple and brief subjective measure of disability in Parkinson's disease. Clin Rehabil. 2001;15(3):241–6.CrossRefPubMed
7.
Zurück zum Zitat Keus S, Nieuwboer A, Bloem B, Borm G, Munneke M. Clinimetric analyses of the modified Parkinson activity scale. Parkinsonism Relat Disord. 2009;15(4):263–9.CrossRefPubMed Keus S, Nieuwboer A, Bloem B, Borm G, Munneke M. Clinimetric analyses of the modified Parkinson activity scale. Parkinsonism Relat Disord. 2009;15(4):263–9.CrossRefPubMed
8.
Zurück zum Zitat Hariz G, Forsgren L. Activities of daily living and quality of life in persons with newly diagnosed Parkinson’s disease according to subtype of disease, and in comparison to healthy controls. Acta Neurol Scand. 2011;123(1):20–7.CrossRefPubMed Hariz G, Forsgren L. Activities of daily living and quality of life in persons with newly diagnosed Parkinson’s disease according to subtype of disease, and in comparison to healthy controls. Acta Neurol Scand. 2011;123(1):20–7.CrossRefPubMed
9.
Zurück zum Zitat Morley D, Selai C, Thompson A. The self-report Barthel Index: preliminary validation in people with Parkinson’s disease. Eur J Neurol. 2012;19(6):927–9.CrossRefPubMed Morley D, Selai C, Thompson A. The self-report Barthel Index: preliminary validation in people with Parkinson’s disease. Eur J Neurol. 2012;19(6):927–9.CrossRefPubMed
10.
Zurück zum Zitat Ramaker C, Marinus J, Stiggelbout AM, van Hilten BJ. Systematic evaluation of rating scales for impairment and disability in Parkinson's disease. Mov Disord. 2002;17(5):867–76.CrossRefPubMed Ramaker C, Marinus J, Stiggelbout AM, van Hilten BJ. Systematic evaluation of rating scales for impairment and disability in Parkinson's disease. Mov Disord. 2002;17(5):867–76.CrossRefPubMed
11.
Zurück zum Zitat Movement Disorder Society Task Force on Rating Scales for Parkinson's Disease. The Unified Parkinson's Disease Rating Scale (UPDRS): status and recommendations. Mov Disord. 2003;18(7):738–50.CrossRef Movement Disorder Society Task Force on Rating Scales for Parkinson's Disease. The Unified Parkinson's Disease Rating Scale (UPDRS): status and recommendations. Mov Disord. 2003;18(7):738–50.CrossRef
12.
Zurück zum Zitat Schrag A, Spottke A, Quinn NP, Dodel R. Comparative responsiveness of Parkinson's disease scales to change over time. Mov Disord. 2009;24(6):813–8.CrossRefPubMed Schrag A, Spottke A, Quinn NP, Dodel R. Comparative responsiveness of Parkinson's disease scales to change over time. Mov Disord. 2009;24(6):813–8.CrossRefPubMed
13.
Zurück zum Zitat Harrison MB, Wylie SA, Frysinger RC, Patrie JT, Huss DS, Currie LJ, et al. UPDRS activity of daily living score as a marker of Parkinson's disease progression. Mov Disord. 2009;24(2):224–30.CrossRefPubMedPubMedCentral Harrison MB, Wylie SA, Frysinger RC, Patrie JT, Huss DS, Currie LJ, et al. UPDRS activity of daily living score as a marker of Parkinson's disease progression. Mov Disord. 2009;24(2):224–30.CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Goetz CG, Tilley BC, Shaftman SR, Stebbins GT, Fahn S, Martinez‐Martin P, et al. Movement Disorder Society‐sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS‐UPDRS): Scale presentation and clinimetric testing results. Mov Disord. 2008;23(15):2129–70.CrossRefPubMed Goetz CG, Tilley BC, Shaftman SR, Stebbins GT, Fahn S, Martinez‐Martin P, et al. Movement Disorder Society‐sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS‐UPDRS): Scale presentation and clinimetric testing results. Mov Disord. 2008;23(15):2129–70.CrossRefPubMed
15.
Zurück zum Zitat Keus SH, Bloem BR, Hendriks EJ, Bredero‐Cohen AB, Munneke M. Evidence‐based analysis of physical therapy in Parkinson's disease with recommendations for practice and research. Mov Disord. 2007;22(4):451–60.CrossRefPubMed Keus SH, Bloem BR, Hendriks EJ, Bredero‐Cohen AB, Munneke M. Evidence‐based analysis of physical therapy in Parkinson's disease with recommendations for practice and research. Mov Disord. 2007;22(4):451–60.CrossRefPubMed
16.
Zurück zum Zitat Brusse KJ, Zimdars S, Zalewski KR, Steffen TM. Testing functional performance in people with Parkinson disease. Phys Ther. 2005;85(2):134–41.PubMed Brusse KJ, Zimdars S, Zalewski KR, Steffen TM. Testing functional performance in people with Parkinson disease. Phys Ther. 2005;85(2):134–41.PubMed
17.
Zurück zum Zitat Gelb DJ, Oliver E, Gilman S. Diagnostic criteria for Parkinson disease. Arch Neurol. 1999;56(1):33–9.CrossRefPubMed Gelb DJ, Oliver E, Gilman S. Diagnostic criteria for Parkinson disease. Arch Neurol. 1999;56(1):33–9.CrossRefPubMed
18.
Zurück zum Zitat Kang Y, Na DL, Hahn S. A validity study on the Korean Mini-Mental State Examination (K-MMSE) in dementia patients. J Korean Neurol Assoc. 1997;15(2):300–8. Kang Y, Na DL, Hahn S. A validity study on the Korean Mini-Mental State Examination (K-MMSE) in dementia patients. J Korean Neurol Assoc. 1997;15(2):300–8.
19.
Zurück zum Zitat Kim S, Won J, Cho K. The validity and reliability of Korean version of Lawton IADL Index. J Korean Geriatr Soc. 2005;9(1):23–9. Kim S, Won J, Cho K. The validity and reliability of Korean version of Lawton IADL Index. J Korean Geriatr Soc. 2005;9(1):23–9.
20.
Zurück zum Zitat Nijkrake MJ, Keus SH, Quist-Anholts GW, Overeem S, De Roode MH, Lindeboom R, et al. Evaluation of a Patient-Specific Index as an outcome measure for physiotherapy in Parkinson's disease. Eur J Phys Rehabil Med. 2009;45(4):507–12.PubMed Nijkrake MJ, Keus SH, Quist-Anholts GW, Overeem S, De Roode MH, Lindeboom R, et al. Evaluation of a Patient-Specific Index as an outcome measure for physiotherapy in Parkinson's disease. Eur J Phys Rehabil Med. 2009;45(4):507–12.PubMed
21.
Zurück zum Zitat Group TCM, Martínez-Martin P, Gil-Nagel A, Gracia LM, Gómez JB, Martínez-Sarriés F, et al. Intermediate scale for assessment of Parkinson's disease. Characteristics and structure. Parkinsonism Relat Disord. 1995;1(2):97–102.CrossRef Group TCM, Martínez-Martin P, Gil-Nagel A, Gracia LM, Gómez JB, Martínez-Sarriés F, et al. Intermediate scale for assessment of Parkinson's disease. Characteristics and structure. Parkinsonism Relat Disord. 1995;1(2):97–102.CrossRef
22.
Zurück zum Zitat Katz S. Assessing self‐maintenance: activities of daily living, mobility, and instrumental activities of daily living. J Am Geriatr Soc. 1983;31(12):721–7.CrossRefPubMed Katz S. Assessing self‐maintenance: activities of daily living, mobility, and instrumental activities of daily living. J Am Geriatr Soc. 1983;31(12):721–7.CrossRefPubMed
23.
Zurück zum Zitat Jung HY, Park BK, Shin HS, Kang YK, Pyun SB, Paik NJ, et al. Development of the Korean version of Modified Barthel Index (K-MBI): multi-center study for subjects with stroke. J Korean Acad Rehabil Med. 2007;31(3):283–97. Jung HY, Park BK, Shin HS, Kang YK, Pyun SB, Paik NJ, et al. Development of the Korean version of Modified Barthel Index (K-MBI): multi-center study for subjects with stroke. J Korean Acad Rehabil Med. 2007;31(3):283–97.
24.
Zurück zum Zitat Kim SY, Won CW, Rho YG, Yoon JL. The validity and reliability of Korean version of Karz ADL index. J Korean Geriatr Soc. 2004;8(2):62–8. Kim SY, Won CW, Rho YG, Yoon JL. The validity and reliability of Korean version of Karz ADL index. J Korean Geriatr Soc. 2004;8(2):62–8.
25.
Zurück zum Zitat Sikkes SA, de Lange-de Klerk ES, Pijnenburg YA, Scheltens P, Uitdehaag BM. A systematic review of Instrumental Activities of Daily Living scales in dementia: room for improvement. J Neurol Neurosurg Psychiatry. 2009;80(1):7–12.CrossRefPubMed Sikkes SA, de Lange-de Klerk ES, Pijnenburg YA, Scheltens P, Uitdehaag BM. A systematic review of Instrumental Activities of Daily Living scales in dementia: room for improvement. J Neurol Neurosurg Psychiatry. 2009;80(1):7–12.CrossRefPubMed
26.
Zurück zum Zitat Hahn H, Yum T, Shin Y, Kim K, Yoon D, Chung K. A standardization study of Beck Depression Inventory in Korea. J Korean Neuropsychiatr Assoc. 1986;25(3):487–500. Hahn H, Yum T, Shin Y, Kim K, Yoon D, Chung K. A standardization study of Beck Depression Inventory in Korea. J Korean Neuropsychiatr Assoc. 1986;25(3):487–500.
27.
Zurück zum Zitat Siddiqui M, Rast S, Lynn M, Auchus A, Pfeiffer R. Autonomic dysfunction in Parkinson's disease: a comprehensive symptom survey. Parkinsonism Relat Disord. 2002;8(4):277–84.CrossRefPubMed Siddiqui M, Rast S, Lynn M, Auchus A, Pfeiffer R. Autonomic dysfunction in Parkinson's disease: a comprehensive symptom survey. Parkinsonism Relat Disord. 2002;8(4):277–84.CrossRefPubMed
28.
Zurück zum Zitat Krupp LB, LaRocca NG, Muir-Nash J, Steinberg AD. The fatigue severity scale: application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol. 1989;46(10):1121–3.CrossRefPubMed Krupp LB, LaRocca NG, Muir-Nash J, Steinberg AD. The fatigue severity scale: application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol. 1989;46(10):1121–3.CrossRefPubMed
29.
Zurück zum Zitat de Boer AG, Wijker W, Speelman JD, de Haes JC. Quality of life in patients with Parkinson's disease: development of a questionnaire. J Neurol Neurosurg Psychiatry. 1996;61(1):70–4.CrossRefPubMedPubMedCentral de Boer AG, Wijker W, Speelman JD, de Haes JC. Quality of life in patients with Parkinson's disease: development of a questionnaire. J Neurol Neurosurg Psychiatry. 1996;61(1):70–4.CrossRefPubMedPubMedCentral
30.
Zurück zum Zitat Hinnell C, Hurt CS, Landau S, Brown RG, Samuel M. Nonmotor versus motor symptoms: how much do they matter to health status in Parkinson's disease? Mov Disord. 2012;27(2):236–41.CrossRefPubMed Hinnell C, Hurt CS, Landau S, Brown RG, Samuel M. Nonmotor versus motor symptoms: how much do they matter to health status in Parkinson's disease? Mov Disord. 2012;27(2):236–41.CrossRefPubMed
Metadaten
Titel
Activities of daily living questionnaire from patients’ perspectives in Parkinson’s disease: a cross-sectional study
verfasst von
Su-Yun Lee
Sung Kwan Kim
Sang-Myung Cheon
Jung-Wook Seo
Min Ah Kim
Jae Woo Kim
Publikationsdatum
01.12.2016
Verlag
BioMed Central
Erschienen in
BMC Neurology / Ausgabe 1/2016
Elektronische ISSN: 1471-2377
DOI
https://doi.org/10.1186/s12883-016-0600-9

Weitere Artikel der Ausgabe 1/2016

BMC Neurology 1/2016 Zur Ausgabe

Neu in den Fachgebieten Neurologie und Psychiatrie

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.